An Audit of the Impact of Tailored Information Delivered Via a Digital Learning Platform
- Conditions
- Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
- Interventions
- Behavioral: training in optimal insulin injection technique
- Registration Number
- NCT04007003
- Lead Sponsor
- Becton, Dickinson and Company
- Brief Summary
The study intends to audit the impact of optimal insulin injection technique on clinical parameters and self-care behaviour of insulin treated diabetes patients in a prospective manner with a follow-up of 6 months. The optimal injection technique is delivered through education via a multimodal tailored approach augmented with a digital 'tailorable' patient learning platform .
The study is conducted in multiple sites across Belgium. Diabetes patients with or without lipohypertrophy will be entered into the audit. The end points will include the impact on use of insulin, long term blood glucose control (HbA1c), hypoglycaemia, glucose variability, needle reuse, patient injection habits and clinician education, training and information inputs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 170
- Type 1 Diabetes Mellitus, or Type 2 Diabetes Mellitus
- Injecting insulin for at least 1 year
- Self-managing injection therapy, including daily glucose monitoring
- Access to a device with internet
- Confident in navigating the internet
- Pregnant or likely to become pregnant during study period
- Impaired cognitive ability which would prevent informed consent
- Syringe only user
- Insulin pump user
- Glucagon-Like Peptide (GLP)-1 receptor agonists therapy only
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description optimal injection technique training in optimal insulin injection technique Subjects will be trained on site regarding optimal insulin injection technique, including avoiding injections in lipohypertrophy areas and proper rotation. Furthermore subjects are provided with access codes to watch online training modules on the Becton Dickinson (BD) and Me(TM) platform
- Primary Outcome Measures
Name Time Method Change in Insulin Use up to 6 months Change in Total Daily Dose of insulin for subjects at baseline and after 6 months; expressed as % and units/24 hrs
- Secondary Outcome Measures
Name Time Method Change in Needle Re-Use up to 6 months Rate of needle re-use by self-reporting at baseline and after 6 months
Change in Glycemic Control up to 6 months Change in HbA1c for subjects at baseline and after 6 months; expressed as % and mmol/mol
Incidence of Hypoglycemic Events up to 6 months Rate of hypoglycemic events requiring 3rd party assistance in 6 months prior to study start (baseline) and during the 6 months of the study
Trial Locations
- Locations (9)
Universitair Ziekenhuis Antwerpen
🇧🇪Antwerpen, Belgium
Imeldaziekenhuis
🇧🇪Bonheiden, Belgium
Universitair Ziekenhuis Brussel
🇧🇪Brussel, Belgium
Virga Jesse Ziekenhuis
🇧🇪Hasselt, Belgium
AZ Turnhout
🇧🇪Turnhout, Belgium
UZ Gent
🇧🇪Gent, Belgium
AZ Groeninge
🇧🇪Kortrijk, Belgium
AZ Nikolaas
🇧🇪Sint-Niklaas, Belgium
AZ Jan Portaels
🇧🇪Vilvoorde, Belgium